LGC’s COVID-19 response

News (ZH) - LGC, an international leader in the life sciences tools sector, is playing an active role in the global response to COVID-19

LGC's innovative SARS-CoV-2 Quality Solutions now includes S gene

News (ZH) - Offers expanded genome coverage to include S gene region

LGC expands SARS-CoV-2 offering to include serology quality solutions

News (ZH) - Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence

NML at LGC joins more than 500 scientists in 18 countries to map COVID-19 effects and treatments in patients’ blood

News (ZH) - Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement

LGC expands SARS-CoV-2 serology offering with 11-member positive-patient Performance Panel

News (ZH) - Panel demonstrates a range of SARS-CoV-2 antibody reactivity

New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes

News (ZH) - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News (ZH) - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News (ZH) - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

Measurement for Recovery (M4R) launched to boost UK innovation

News (ZH) - M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.

LGC COVID-19 antibody assay processes up to 40,000 tests per day in UK

News (ZH) - First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection